The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

Global drugmaker, GlaxoSmithKline ... The company also sells several pharmaceutical products, such as vaccines and antibiotic, augmentin.

India’s pharmaceutical market is valued at over Rs 2.2 lakh crore, growing at a little over 8%. In January, price increases contributed over 5% to growth, new product introductions added 2.6% ...

Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and ...

GSK Pharma board ... new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India.

GlaxoSmithKline ... of the total deaths in India. MD Sridhar Venkatesh said, “As part of our parent GSK Plc’s new ambition to create two world class companies in pharmaceuticals and consumer ...

expanding patient access across India. In the vaccines segment, GlaxoSmithKline Pharmaceuticals maintained leadership in the self-pay private market for pediatric vaccines. Meanwhile, its adult ...

Formerly head of the pharma’s consumer products division, Walmsley worked in marketing and management at L’Oreal for 17 years before joining GSK. After launching the company’s Q1 results ...

India's GlaxoSmithKline Pharma reports higher profit on strong ... with Pfizer worth a combined $897 million to manufacture products for the U.S. pharmaceutical giant. May 19, 2023 Abbott's ...

(Reuters) - India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian ...